Type 1 equilibrative nucleoside transporter regulates astrocyte-specific glial fibrillary acidic protein expression in the striatum

David J. Hinton, Moonnoh R. Lee, Jin Sung Jang, Doo Sup Choi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Adenosine signaling has been implicated in several neurological and psychiatric disorders. Previously, we found that astrocytic excitatory amino acid transporter 2 (EAAT2) and aquaporin 4 (AQP4) are downregulated in the striatum of mice lacking type 1 equilibrative nucleoside transporter (ENT1). Methods: To further investigate the gene expression profile in the striatum, we preformed Illumina Mouse Whole Genome BeadChip microarray analysis of the caudate-putamen (CPu) and nucleus accumbens (NAc) in ENT1 null mice. Gene expression was validated by RT-PCR, Western blot, and immunofluorescence. Using transgenic mice expressing enhanced green fluorescence protein (EGFP) under the control of the glial fibrillary acidic protein (GFAP) promoter, we examined EGFP expression in an ENT1 null background. Results: Glial fibrillary acidic protein was identified as a top candidate gene that was reduced in ENT1 null mice compared to wild-type littermates. Furthermore, EGFP expression was significantly reduced in GFAP-EGFP transgenic mice in an ENT1 null background in both the CPu and NAc. Finally, pharmacological inhibition or siRNA knockdown of ENT1 in cultured astrocytes also reduced GFAP mRNA levels. Conclusions: Overall, our findings demonstrate that ENT1 regulates GFAP expression and possibly astrocyte function.

Original languageEnglish (US)
Pages (from-to)903-914
Number of pages12
JournalBrain and Behavior
Volume4
Issue number6
DOIs
StatePublished - Nov 1 2014

Fingerprint

Equilibrative Nucleoside Transporter 1
Glial Fibrillary Acidic Protein
Astrocytes
Fluorescence
Caudate Nucleus
Putamen
Nucleus Accumbens
Excitatory Amino Acid Transporter 4
Transgenic Mice
Excitatory Amino Acid Transporter 2
Proteins
Aquaporin 4
Microarray Analysis
Nervous System Diseases
Transcriptome
Adenosine
Small Interfering RNA
Fluorescent Antibody Technique
Psychiatry
Down-Regulation

Keywords

  • GFAP
  • Adenosine transporter
  • Astrocyte
  • ENT1
  • Microarray

ASJC Scopus subject areas

  • Behavioral Neuroscience

Cite this

Type 1 equilibrative nucleoside transporter regulates astrocyte-specific glial fibrillary acidic protein expression in the striatum. / Hinton, David J.; Lee, Moonnoh R.; Jang, Jin Sung; Choi, Doo Sup.

In: Brain and Behavior, Vol. 4, No. 6, 01.11.2014, p. 903-914.

Research output: Contribution to journalArticle

@article{00b10a2a9b154be1ace748f0718f4dae,
title = "Type 1 equilibrative nucleoside transporter regulates astrocyte-specific glial fibrillary acidic protein expression in the striatum",
abstract = "Background: Adenosine signaling has been implicated in several neurological and psychiatric disorders. Previously, we found that astrocytic excitatory amino acid transporter 2 (EAAT2) and aquaporin 4 (AQP4) are downregulated in the striatum of mice lacking type 1 equilibrative nucleoside transporter (ENT1). Methods: To further investigate the gene expression profile in the striatum, we preformed Illumina Mouse Whole Genome BeadChip microarray analysis of the caudate-putamen (CPu) and nucleus accumbens (NAc) in ENT1 null mice. Gene expression was validated by RT-PCR, Western blot, and immunofluorescence. Using transgenic mice expressing enhanced green fluorescence protein (EGFP) under the control of the glial fibrillary acidic protein (GFAP) promoter, we examined EGFP expression in an ENT1 null background. Results: Glial fibrillary acidic protein was identified as a top candidate gene that was reduced in ENT1 null mice compared to wild-type littermates. Furthermore, EGFP expression was significantly reduced in GFAP-EGFP transgenic mice in an ENT1 null background in both the CPu and NAc. Finally, pharmacological inhibition or siRNA knockdown of ENT1 in cultured astrocytes also reduced GFAP mRNA levels. Conclusions: Overall, our findings demonstrate that ENT1 regulates GFAP expression and possibly astrocyte function.",
keywords = "GFAP, Adenosine transporter, Astrocyte, ENT1, Microarray",
author = "Hinton, {David J.} and Lee, {Moonnoh R.} and Jang, {Jin Sung} and Choi, {Doo Sup}",
year = "2014",
month = "11",
day = "1",
doi = "10.1002/brb3.283",
language = "English (US)",
volume = "4",
pages = "903--914",
journal = "Brain and Behavior",
issn = "2157-9032",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Type 1 equilibrative nucleoside transporter regulates astrocyte-specific glial fibrillary acidic protein expression in the striatum

AU - Hinton, David J.

AU - Lee, Moonnoh R.

AU - Jang, Jin Sung

AU - Choi, Doo Sup

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Background: Adenosine signaling has been implicated in several neurological and psychiatric disorders. Previously, we found that astrocytic excitatory amino acid transporter 2 (EAAT2) and aquaporin 4 (AQP4) are downregulated in the striatum of mice lacking type 1 equilibrative nucleoside transporter (ENT1). Methods: To further investigate the gene expression profile in the striatum, we preformed Illumina Mouse Whole Genome BeadChip microarray analysis of the caudate-putamen (CPu) and nucleus accumbens (NAc) in ENT1 null mice. Gene expression was validated by RT-PCR, Western blot, and immunofluorescence. Using transgenic mice expressing enhanced green fluorescence protein (EGFP) under the control of the glial fibrillary acidic protein (GFAP) promoter, we examined EGFP expression in an ENT1 null background. Results: Glial fibrillary acidic protein was identified as a top candidate gene that was reduced in ENT1 null mice compared to wild-type littermates. Furthermore, EGFP expression was significantly reduced in GFAP-EGFP transgenic mice in an ENT1 null background in both the CPu and NAc. Finally, pharmacological inhibition or siRNA knockdown of ENT1 in cultured astrocytes also reduced GFAP mRNA levels. Conclusions: Overall, our findings demonstrate that ENT1 regulates GFAP expression and possibly astrocyte function.

AB - Background: Adenosine signaling has been implicated in several neurological and psychiatric disorders. Previously, we found that astrocytic excitatory amino acid transporter 2 (EAAT2) and aquaporin 4 (AQP4) are downregulated in the striatum of mice lacking type 1 equilibrative nucleoside transporter (ENT1). Methods: To further investigate the gene expression profile in the striatum, we preformed Illumina Mouse Whole Genome BeadChip microarray analysis of the caudate-putamen (CPu) and nucleus accumbens (NAc) in ENT1 null mice. Gene expression was validated by RT-PCR, Western blot, and immunofluorescence. Using transgenic mice expressing enhanced green fluorescence protein (EGFP) under the control of the glial fibrillary acidic protein (GFAP) promoter, we examined EGFP expression in an ENT1 null background. Results: Glial fibrillary acidic protein was identified as a top candidate gene that was reduced in ENT1 null mice compared to wild-type littermates. Furthermore, EGFP expression was significantly reduced in GFAP-EGFP transgenic mice in an ENT1 null background in both the CPu and NAc. Finally, pharmacological inhibition or siRNA knockdown of ENT1 in cultured astrocytes also reduced GFAP mRNA levels. Conclusions: Overall, our findings demonstrate that ENT1 regulates GFAP expression and possibly astrocyte function.

KW - GFAP

KW - Adenosine transporter

KW - Astrocyte

KW - ENT1

KW - Microarray

UR - http://www.scopus.com/inward/record.url?scp=84911363465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911363465&partnerID=8YFLogxK

U2 - 10.1002/brb3.283

DO - 10.1002/brb3.283

M3 - Article

C2 - 25365803

AN - SCOPUS:84911363465

VL - 4

SP - 903

EP - 914

JO - Brain and Behavior

JF - Brain and Behavior

SN - 2157-9032

IS - 6

ER -